Financial Ratios TSMC (Taiwan Semiconductor Manufacturing Company)
Equities
2330
TW0002330008
Semiconductors
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,055.00 TWD | +1.93% |
|
+2.43% | -1.86% |
06-20 | US may target Samsung, Hynix, TSMC operations in China, sources say | RE |
06-20 | US may target Samsung, Hynix, TSMC operations in China, sources say | RE |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 14.1 | 12.53 | 16.14 | 10.97 | 13.53 | |||||
Return on Total Capital | 17.56 | 15.79 | 20.69 | 13.84 | 16.8 | |||||
Return On Equity % | 29.84 | 29.7 | 39.64 | 26 | 30.04 | |||||
Return on Common Equity | 29.84 | 29.69 | 39.76 | 26.18 | 30.29 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 53.1 | 51.63 | 59.56 | 54.36 | 56.12 | |||||
SG&A Margin | 2.66 | 2.8 | 2.8 | 3.31 | 3.35 | |||||
EBITDA Margin % | 66.62 | 67.2 | 68.53 | 66.84 | 68.3 | |||||
EBITA Margin % | 42.58 | 41.27 | 49.74 | 42.81 | 45.85 | |||||
EBIT Margin % | 42.32 | 40.96 | 49.56 | 42.63 | 45.72 | |||||
Income From Continuing Operations Margin % | 38.69 | 37.61 | 44.92 | 38.75 | 40.51 | |||||
Net Income Margin % | 38.67 | 37.58 | 44.9 | 38.79 | 40.54 | |||||
Net Avail. For Common Margin % | 38.67 | 37.58 | 44.9 | 38.79 | 40.54 | |||||
Normalized Net Income Margin | 27.2 | 26.08 | 31.61 | 28.36 | 30.43 | |||||
Levered Free Cash Flow Margin | 14.34 | -2.59 | 12.5 | 3.82 | 23.77 | |||||
Unlevered Free Cash Flow Margin | 14.43 | -2.38 | 12.83 | 4.17 | 24 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.53 | 0.49 | 0.52 | 0.41 | 0.47 | |||||
Fixed Assets Turnover | 0.91 | 0.88 | 0.95 | 0.74 | 0.91 | |||||
Receivables Turnover (Average Receivables) | 9.37 | 9.22 | 10.54 | 9.98 | 12.21 | |||||
Inventory Turnover (Average Inventory) | 5.7 | 4.65 | 4.42 | 4.18 | 4.71 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.77 | 2.17 | 2.17 | 2.4 | 2.44 | |||||
Quick Ratio | 1.54 | 1.9 | 1.93 | 2.07 | 2.13 | |||||
Operating Cash Flow to Current Liabilities | 1.33 | 1.5 | 1.71 | 1.36 | 1.44 | |||||
Days Sales Outstanding (Average Receivables) | 39.05 | 39.59 | 34.63 | 36.58 | 29.97 | |||||
Days Outstanding Inventory (Average Inventory) | 64.19 | 78.54 | 82.58 | 87.33 | 77.65 | |||||
Average Days Payable Outstanding | 21.8 | 19.9 | 20.36 | 20.43 | 18.39 | |||||
Cash Conversion Cycle (Average Days) | 81.45 | 98.22 | 96.85 | 103.48 | 89.24 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 19.97 | 34.82 | 30.09 | 28.32 | 24.29 | |||||
Total Debt / Total Capital | 16.65 | 25.83 | 23.13 | 22.07 | 19.54 | |||||
LT Debt/Equity | 14.95 | 29.21 | 29.35 | 27.19 | 22.83 | |||||
Long-Term Debt / Total Capital | 12.46 | 21.67 | 22.56 | 21.19 | 18.37 | |||||
Total Liabilities / Total Assets | 32.97 | 41.73 | 40.37 | 37.04 | 35.39 | |||||
EBIT / Interest Expense | 272.3 | 120.1 | 95.5 | 76.79 | 126.08 | |||||
EBITDA / Interest Expense | 429.91 | 197.51 | 132.3 | 120.7 | 188.71 | |||||
(EBITDA - Capex) / Interest Expense | 186.22 | 42.51 | 40.16 | 41.55 | 97.62 | |||||
Total Debt / EBITDA | 0.41 | 0.71 | 0.57 | 0.68 | 0.53 | |||||
Net Debt / EBITDA | -0.48 | -0.42 | -0.45 | -0.48 | -0.69 | |||||
Total Debt / (EBITDA - Capex) | 0.95 | 3.28 | 1.89 | 1.98 | 1.02 | |||||
Net Debt / (EBITDA - Capex) | -1.12 | -1.95 | -1.48 | -1.41 | -1.34 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 25.17 | 18.53 | 42.61 | -4.51 | 33.89 | |||||
Gross Profit, 1 Yr. Growth % | 43.35 | 15.24 | 64.53 | -12.85 | 38.23 | |||||
EBITDA, 1 Yr. Growth % | 35.93 | 19.58 | 45.57 | -6.87 | 36.82 | |||||
EBITA, 1 Yr. Growth % | 51.06 | 14.88 | 72.14 | -17.82 | 43.39 | |||||
EBIT, 1 Yr. Growth % | 50.82 | 14.73 | 72.56 | -17.88 | 43.6 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 50.04 | 15.23 | 70.31 | -17.62 | 39.95 | |||||
Net Income, 1 Yr. Growth % | 50 | 15.19 | 70.4 | -17.51 | 39.92 | |||||
Normalized Net Income, 1 Yr. Growth % | 48.59 | 13.65 | 72.82 | -14.33 | 43.66 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 49.98 | 15.2 | 70.39 | -17.51 | 39.93 | |||||
Accounts Receivable, 1 Yr. Growth % | 4.48 | 35.79 | 16.66 | -12.71 | 34.74 | |||||
Inventory, 1 Yr. Growth % | 65.52 | 40.59 | 14.52 | 13.5 | 14.69 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 15.6 | 26.81 | 36.25 | 13.49 | 5.48 | |||||
Total Assets, 1 Yr. Growth % | 21.9 | 34.95 | 33.26 | 11.43 | 20.96 | |||||
Tangible Book Value, 1 Yr. Growth % | 13.94 | 17.41 | 36.34 | 17.69 | 24.04 | |||||
Common Equity, 1 Yr. Growth % | 14.08 | 17.23 | 35.85 | 17.42 | 23.99 | |||||
Cash From Operations, 1 Yr. Growth % | 33.74 | 35.19 | 44.82 | -22.89 | 47.04 | |||||
Capital Expenditures, 1 Yr. Growth % | 10.17 | 65.44 | 29.01 | -12.27 | 0.65 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -27.52 | -122.33 | -606.14 | -67.85 | 739.35 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -27.59 | -120.35 | -652.72 | -65.91 | 676.33 | |||||
Dividend Per Share, 1 Yr. Growth % | 5.26 | 10 | -0 | 18.18 | 30.77 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 13.95 | 21.8 | 30.02 | 16.7 | 13.07 | |||||
Gross Profit, 2 Yr. CAGR % | 19.19 | 28.53 | 37.7 | 19.74 | 9.76 | |||||
EBITDA, 2 Yr. CAGR % | 14.77 | 27.4 | 31.88 | 16.44 | 12.88 | |||||
EBITA, 2 Yr. CAGR % | 21.04 | 31.57 | 40.54 | 18.94 | 8.55 | |||||
EBIT, 2 Yr. CAGR % | 20.92 | 31.38 | 40.72 | 19.04 | 8.59 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 19.46 | 29.87 | 41.07 | 18.45 | 7.38 | |||||
Net Income, 2 Yr. CAGR % | 19.44 | 29.82 | 41.08 | 18.56 | 7.43 | |||||
Normalized Net Income, 2 Yr. CAGR % | 20.35 | 29.79 | 40.17 | 21.68 | 10.94 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 19.43 | 29.82 | 41.07 | 18.56 | 7.44 | |||||
Accounts Receivable, 2 Yr. CAGR % | 6.32 | 19.11 | 25.86 | 0.91 | 8.45 | |||||
Inventory, 2 Yr. CAGR % | 15.35 | 52.55 | 26.89 | 14.01 | 14.09 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 21.53 | 21.08 | 31.45 | 24.35 | 9.41 | |||||
Total Assets, 2 Yr. CAGR % | 14.93 | 28.26 | 34.11 | 21.86 | 16.1 | |||||
Tangible Book Value, 2 Yr. CAGR % | 5.35 | 15.94 | 27.04 | 26.67 | 20.82 | |||||
Common Equity, 2 Yr. CAGR % | 5.54 | 15.92 | 26.71 | 26.3 | 20.66 | |||||
Cash From Operations, 2 Yr. CAGR % | 19.72 | 34.46 | 39.92 | 5.67 | 6.48 | |||||
Capital Expenditures, 2 Yr. CAGR % | 26.78 | 35.01 | 46.1 | 6.39 | -6.03 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 16.58 | -61.17 | 19.26 | 21.6 | 63.57 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 16.19 | -62.94 | 20.4 | 31.02 | 62.05 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.8 | 7.61 | 4.88 | 8.71 | 24.32 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 11.07 | 15.45 | 28.38 | 17.3 | 22.17 | |||||
Gross Profit, 3 Yr. CAGR % | 12.85 | 17.86 | 39.55 | 18.23 | 25.61 | |||||
EBITDA, 3 Yr. CAGR % | 11.45 | 16.35 | 33.15 | 17.44 | 22.87 | |||||
EBITA, 3 Yr. CAGR % | 13.63 | 18.96 | 43.83 | 17.52 | 26.59 | |||||
EBIT, 3 Yr. CAGR % | 13.59 | 18.82 | 43.88 | 17.6 | 26.72 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 14.52 | 18.03 | 42.15 | 17.91 | 25.22 | |||||
Net Income, 3 Yr. CAGR % | 14.5 | 18 | 42.14 | 17.97 | 25.29 | |||||
Normalized Net Income, 3 Yr. CAGR % | 13.65 | 18.07 | 42.79 | 18.95 | 28.6 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 14.51 | 18.01 | 42.14 | 17.97 | 25.29 | |||||
Accounts Receivable, 3 Yr. CAGR % | 6.09 | 15.35 | 18.29 | 11.41 | 11.12 | |||||
Inventory, 3 Yr. CAGR % | 22.96 | 23.21 | 38.64 | 22.26 | 14.24 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 14.22 | 23.26 | 25.94 | 25.17 | 17.71 | |||||
Total Assets, 3 Yr. CAGR % | 11.5 | 21.25 | 29.91 | 26.08 | 21.56 | |||||
Tangible Book Value, 3 Yr. CAGR % | 7.22 | 9.22 | 22.38 | 23.84 | 25.79 | |||||
Common Equity, 3 Yr. CAGR % | 7.38 | 9.3 | 22.21 | 23.53 | 25.53 | |||||
Cash From Operations, 3 Yr. CAGR % | 12.02 | 24.67 | 37.83 | 14.72 | 17.98 | |||||
Capital Expenditures, 3 Yr. CAGR % | 15.34 | 38.54 | 32.98 | 23.26 | 4.44 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 6.87 | -33.7 | 1.2 | -25.38 | 130.87 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 6.64 | -35.85 | 1.81 | -23.36 | 136.47 | |||||
Dividend Per Share, 3 Yr. CAGR % | 7.72 | 11.2 | 5.01 | 9.14 | 15.62 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.69 | 10.86 | 18.29 | 15.95 | 22.02 | |||||
Gross Profit, 5 Yr. CAGR % | 11.62 | 11.53 | 22.2 | 18.61 | 26.77 | |||||
EBITDA, 5 Yr. CAGR % | 10.46 | 12.2 | 19.21 | 16.36 | 24.64 | |||||
EBITA, 5 Yr. CAGR % | 12.02 | 11.52 | 23.7 | 18.91 | 28.52 | |||||
EBIT, 5 Yr. CAGR % | 11.99 | 11.47 | 23.75 | 18.91 | 28.56 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 11.34 | 12.47 | 24.13 | 18.2 | 27.06 | |||||
Net Income, 5 Yr. CAGR % | 11.33 | 12.45 | 24.13 | 18.22 | 27.08 | |||||
Normalized Net Income, 5 Yr. CAGR % | 12.2 | 11.4 | 23.58 | 19.5 | 29.08 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 11.32 | 12.46 | 24.13 | 18.23 | 27.09 | |||||
Accounts Receivable, 5 Yr. CAGR % | 11.28 | 8.93 | 13.59 | 9.34 | 14.25 | |||||
Inventory, 5 Yr. CAGR % | 15.42 | 31.73 | 24.52 | 19.45 | 28.25 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 13.16 | 15.01 | 20.82 | 23.7 | 19.05 | |||||
Total Assets, 5 Yr. CAGR % | 10.74 | 14.58 | 20.04 | 21.49 | 24.2 | |||||
Tangible Book Value, 5 Yr. CAGR % | 9.1 | 9.76 | 14.56 | 15.89 | 21.75 | |||||
Common Equity, 5 Yr. CAGR % | 9.15 | 9.79 | 14.55 | 15.81 | 21.59 | |||||
Cash From Operations, 5 Yr. CAGR % | 9.2 | 15.55 | 22.44 | 16.69 | 24.31 | |||||
Capital Expenditures, 5 Yr. CAGR % | 14.52 | 20.67 | 26.78 | 24.65 | 15.73 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 1.48 | -25.13 | 12.47 | -10.16 | 20.3 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 1.39 | -26.58 | 12.75 | -8.83 | 20.35 | |||||
Dividend Per Share, 5 Yr. CAGR % | 10.76 | 9.46 | 6.58 | 10.2 | 12.34 |
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition